Jump to content

Paula Cannon

From Wikipedia, the free encyclopedia
Paula Cannon
NationalityBritish
Alma materUniversity of Liverpool, UK
Scientific career
FieldsGenetics
InstitutionsUniversity of Southern California (USC)

Paula Cannon is a British geneticist and virologist, Distinguished Professor of Molecular Microbiology & Immunology at the University of Southern California.[1] She is a specialist in gene therapy, hematopoietic stem cells, and human immunodeficiency virus (HIV) with particular interest in gene editing and humanized mice.

Personal life and education

[edit]

She received her PhD from the University of Liverpool, and postdoctoral training at both Oxford and Harvard[1]

Academic career

[edit]

Cannon's recent work is aimed at disrupting the CCR viral co-receptor, CCR5, using zinc finger nucleases(ZFNs). She also studies SARS-CoV-2 and highly pathogenic hemorrhagic fever viruses, including Ebola and Lassa fever viruses.[1]

Selected publications

[edit]

Her most cited peer-reviewed publications are:

  • Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids research. 1995 Feb 25;23(4):628-33. [2] open access Cited 932 times, according to Google Scholar,[2]
  • Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nature Biotechnology. 2010 Aug;28(8):839-47. Cited 762 times, according to Google Scholar [2]
  • Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nature Medicine. 2016 Aug;22(8):839-50. [3] Cited 375 times, according to Google Scholar [2]
  • Gardner MR, Kattenhorn LM, Kondur HR, Von Schaewen M, Dorfman T, Chiang JJ, Haworth KG, Decker JM, Alpert MD, Bailey CC, Neale ES. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges. Nature. 2015 Mar;519(7541):87-91. [4] Cited 275 times, according to Google Scholar [2]
  • Wang J, Exline CM, DeClercq JJ, Llewellyn GN, Hayward SB, Li PW, Shivak DA, Surosky RT, Gregory PD, Holmes MC, Cannon PM. Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nature biotechnology. 2015 Dec;33(12):1256-63. Cited 242 times, according to Google Scholar [2]

References

[edit]
  1. ^ a b c "Paula Cannon, PhD | Keck School of Medicine of USC". 31 July 2018. Retrieved 2021-11-05.
  2. ^ a b c d e Google Scholar author page [1] Accessed Nov 5, 2021
[edit]